National

Zydus Cadila to seek nod for two-dose regimen of its approved vaccine in India

Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India’s drugs regulator for emergency use in India on August 20.

migrator

Updated:13th Sep, 2021 at 9:48 AM

New Delhi

The trials for the two-dose regimen are underway. 2mg of the vaccine has been prescribed in each dose of the present-day three-dose vaccine i.e. total of 6 mg. The company is now evaluating a 2 dose regime with 3mg in each dose. The vaccine is said to be pathbreaking as it is for the first time that a technologically advanced vaccine has been successfully developed on the Plasmid DNA platform for human use.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Zydus Cadila to seek nod for two-dose regimen of its approved vaccine in India

Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India’s drugs regulator for emergency use in India on August 20.

Also Read

Parandur airport project to be scrapped, alternative sites identified: CM Vijay

Abandoning Parandur airport project could affect industrial growth, says Thangam Thennarasu

Tamil Nadu announces 3 free LPG cylinders a year under Annapoorani Super Six scheme

Tamil Nadu to expand free bus travel scheme for women from October 2

New Zealand's prime minister proposes banning children from using social media